학술논문
Impact of lung function impairment after allogeneic hematopoietic stem cell transplantation.
Document Type
Article
Author
Kishida, Yuya; Shingai, Naoki; Hara, Konan; Yomota, Makiko; Kato, Chika; Sakai, Satoshi; Kambara, Yasuhiro; Atsuta, Yuya; Konuma, Ryosuke; Wada, Atsushi; Murakami, Daisuke; Nakashima, Shiori; Uchibori, Yusuke; Onai, Daishi; Hamamura, Atsushi; Nishijima, Akihiko; Toya, Takashi; Shimizu, Hiroaki; Najima, Yuho; Kobayashi, Takeshi
Source
Subject
*HEMATOPOIETIC stem cell transplantation
*LUNGS
*PULMONARY function tests
*VITAL capacity (Respiration)
*
*
*
Language
ISSN
2045-2322
Abstract
Late-onset noninfectious pulmonary complications (LONIPC) are a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). However, the clinical impact of lung function deterioration itself in long-term adult survivors of HSCT remains to be fully investigated. This retrospective, longitudinal study aimed to investigate pulmonary function following HSCT in terms of its change and the clinical significance of its decline. We examined 167 patients who survived for at least 2 years without relapse. The median follow-up period was 10.3 years. A linear mixed-effects model showed that the slope of pulmonary function tests values, including percent vital capacity (%VC), percent forced expiratory volume in one second (%FEV1), and FEV1/forced VC ratio (FEV1%), decreased over time. The cumulative incidence of newly obstructive and restrictive lung function impairment (LFI) at 10 years was 15.7% and 19.5%, respectively. Restrictive LFI was a significant, independent risk factor for overall survival (hazard ratio 7.11, P = 0.007) and non-relapse mortality (hazard ratio 12.19, P = 0.003). Our data demonstrated that lung function declined over time after HSCT and that the decline itself had a significant impact on survival regardless of LONIPC. [ABSTRACT FROM AUTHOR]